Cost-effectiveness analysis of docetaxel (Taxotere®) vs. 5-fluorouracil in combined therapy in the initial phases of breast cancer

  1. Martín-Jiménez, M.
  2. Rodríguez-Lescure, Á.
  3. Ruiz-Borrego, M.
  4. Seguí-Palmer, M.-Á.
  5. Brosa-Riestra, M.
Zeitschrift:
Clinical and Translational Oncology

ISSN: 1699-048X

Datum der Publikation: 2009

Ausgabe: 11

Nummer: 1

Seiten: 41-47

Art: Artikel

DOI: 10.1007/S12094-009-0309-Y GOOGLE SCHOLAR